Annovis Bio, Inc. (ANVS) stock analysis and AI prediction
The company facts of Annovis Bio, Inc., with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Annovis Bio, Inc.
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
- Sector
- Healthcare
- Exchange
- NYSE
- Market value
- $46.4 million
- Size
- Micro cap
- Employees
- 7
- Headquarters
- MALVERN, PA
- Listed since
- Jan. 29, 2020
- Website
- annovisbio.com
More Healthcare stocks
Other micro cap stocks
Keep going
ANVS questions
What is the AI prediction for ANVS stock?
Each market day our model rates Annovis Bio, Inc. (ANVS) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the ANVS prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for ANVS?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see ANVS options?
The ANVS options page opens its calls and puts, with price, volume, implied volatility and the Greeks.